Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of phenylpyridazines. It features a triazolopyridazine core with a phenolic substituent and is structurally described as 4‑[(6‑phenyl[1,2,4]triazolo[4,3‑b]pyridazin‑3‑yl)methyl]phenol. The molecular formula is C18H14N4O and its average molecular weight is approximately 302.33 g/mol. There are no approved medical indications or clinical trials reported for this compound; it remains an experimental molecule with no established mechanism of action or therapeutic use in humans as of now. Its structure suggests potential for kinase inhibition (notably MET/Hepatocyte growth factor receptor), but there are no published data confirming such activity for this specific derivative.[1][2]
- Other names
- Phenol, 4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methyl]940057–42–1
Beyond the preview
Go deeper on 4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol.